GeNeuro

Menu  |  Content
Twitter Linkedin YouTube Home Print
  • Français
  • English
Retour à l’accueil Menu de navigation
  • Home
  • HERV Approach
  • COVID-19
  • Clinical Trials
  • News & Media
  • Investors
  • About GeNeuro
  • Contact
January 2023 New presentation available

News

GeNeuro announces recruitment of first patients in all five Swiss centers in the first personalized medicine clinical trial against long-COVID assessing temelimab

Read more

HERV Approach

GeNeuro is pursuing a novel approach for treating autoimmune diseases by seeking to block mechanisms suspected of participating to their onset and development.

Read more

© 2023 GeNeuro SA

Legal Notice

 

3, Chemin du Pré-Fleuri
CH-1228 Plan-les-Ouates
Geneva, Switzerland

 

+41 22 552 48 00

contact@geneuro.com